Adjuvant galantamine for cognitive dysfunction in a patient with bipolar disorder.
Dias
Vasco Videira
VV
Autonomous University of Lisbon, Lisbon, Portugal.
Brissos
Sofia
S
Gorman
Jack M
JM
D000544:Alzheimer Disease / Q000175:diagnosis; D018692:Antimanic Agents / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000150:complications* / Q000188:drug therapy*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D003072:Cognition Disorders / Q000150:complications* / Q000188:drug therapy*; D003937:Diagnosis, Differential; D005260:Female; D005702:Galantamine / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D009483:Neuropsychological Tests; D012720:Severity of Illness Index
D018692:Antimanic Agents; D002800:Cholinesterase Inhibitors; D005702:Galantamine